Key result
Continuing low-dose aspirin (100 mg/day) perioperatively during total hip or knee arthroplasty did not significantly affect blood loss, operative time, or haemoglobin drop compared to controls.
Why the study?
Does continuing low-dose aspirin perioperatively increase bleeding risk or affect surgical outcomes in patients undergoing total hip or knee arthroplasty?
Cohort (n=139)
Does continuing low-dose aspirin perioperatively increase bleeding risk or affect surgical outcomes in patients undergoing total hip or knee arthroplasty?
Continuing low-dose aspirin perioperatively during total hip or knee arthroplasty appears safe and does not significantly increase blood loss or affect wound healing.
No takes yet. Share an insight, caveat, or question.
May support continuing low-dose aspirin perioperatively in arthroplasty; hypothesis-generating pending randomized confirmation.
Cossetto et al. (2012) conducted a cohort in Total hip arthroplasty (THA) or total knee arthroplasty (TKA) (n=139). Low-dose aspirin vs. Controls (not on aspirin) was evaluated on Blood loss, operative time, surgical wound healing, and drop in haemoglobin level. Continuing low-dose aspirin (100 mg/day) perioperatively during total hip or knee arthroplasty did not significantly affect blood loss, operative time, or haemoglobin drop compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: